CHC
MRNA icon

City Holding Co’s Moderna MRNA Stock Holding History

City Holding Co’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-40
Closed -$2.67K – 473
2024
Q3 		$2.67K Hold
40
– – ﹤0.01% 437
2024
Q2 		$4.75K Hold
40
– – ﹤0.01% 417
2024
Q1 		$4.26K Hold
40
– – ﹤0.01% 446
2023
Q4 		$3.98K Hold
40
– – ﹤0.01% 448
2023
Q3 		$4.13K Hold
40
– – ﹤0.01% 452
2023
Q2 		$4.86K Hold
40
– – ﹤0.01% 452
2023
Q1 		$6.14K Hold
40
– – ﹤0.01% 457
2022
Q4 		$7.18K Hold
40
– – ﹤0.01% 449
2022
Q3 		$5K Hold
40
– – ﹤0.01% 467
2022
Q2 		$6K Hold
40
– – ﹤0.01% 450
2022
Q1 		$7K Hold
40
– – ﹤0.01% 457
2021
Q4 		$6K Buy
40
+10
+33% +$2.92K ﹤0.01% 459
2021
Q3 		$12K Hold
30
– – ﹤0.01% 421
2021
Q2 		$7K Hold
30
– – ﹤0.01% 447
2021
Q1 		$4K Hold
30
– – ﹤0.01% 459
2020
Q4 		$3K Buy
30
+10
+50% +$1.01K ﹤0.01% 460
2020
Q3 		$1K Buy
+20
New +$1.39K ﹤0.01% 490

Other funds holding MRNA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return

City Holding Co's MRNA Position: Q4 2024 in Review

City Holding Co sold out of Moderna (MRNA) in Q4 2024, closing a stake of 40 shares — an estimated $2.67K sold.

City Holding Co first reported a position in MRNA in Q3 2020 and held it in 17 quarters. The position peaked at $12K in Q3 2021. 745 funds tracked by Wall St. Rank hold MRNA as of Q4 2024.

  • City Holding Co reported no remaining Moderna position as of Q4 2024 after selling out during the quarter.
  • City Holding Co sold 40 Moderna shares in Q4 2024, an estimated $2.67K.
  • City Holding Co first reported a position in Moderna in Q3 2020 and held it in 17 quarters.
  • City Holding Co's Moderna position peaked at $12K in Q3 2021.
  • 745 funds tracked by Wall St. Rank held Moderna as of Q4 2024.

Based on City Holding Co's 13F filing for Q4 2024, filed 16 Jan 2025.